OPTH (OPTH) is a publicly traded the market company. As of May 20, 2026, OPTH trades at $5.87 with a market cap of $0 and a P/E ratio of 0.00. OPTH moved +0.00% today. Year to date, OPTH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces OPTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Optimi Health Sets US$15 Million 2.4 Million-Share Offering, Nasdaq Uplisting May 20: Optimi Health priced an oversubscribed US$15 million offering of 2.4 million shares at US$6.25, with a 360,000-share overallotment option. Shares begin trading on the Nasdaq Capital Market under OPTH on May 20 after a 1-for-30 consolidation, with net proceeds funding production scale and U.S. market expansion.
| Metric | Value |
|---|---|
| Price | $5.87 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 1.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
OPTH analyst coverage data. Average price target: $0.00.